Health Canada’s Approach to Low Risk Veterinary Health Products: Interim Notification Pilot Program Veterinary Drugs Directorate-Health Canada Presented.

Slides:



Advertisements
Similar presentations
Biopharmaceutical Quality
Advertisements

Safety Guidelines Illness and Injury Prevention Safety Guidelines Illness and Injury Prevention 2.01 Understand safety procedures 1.
Merton V. Smith, Ph.D., J.D. Director International Programs Center for Veterinary Medicine U.S. Food and Drug Administration Governance of Veterinary.
Steven D. Vaughn, DVM Director Office of New Animal Drug Evaluation Center for Veterinary Medicine U. S. Food and Drug Administration June 6, 2012 Embracing.
TEXAS SOUTHERN UNIVERSITY INSTITUTIONAL ANIMAL CARE AND USE PROGRAM WORKSHOP OFFICE OF RESEARCH LINDA M. GARDINER, Ph.D. DIRECTOR RESEARCH ENHANCEMENT.
The United States Experience Implementing the WTO SPS Agreement Hangzhou, China December 2008 Roseanne Freese Senior WTO SPS Affairs Officer United States.
International Standards for Food Quality and Safety – Accomplishments of the Codex Alimentarius Commission International Symposium on Food Safety Standards.
Regulation and Safety Assessment of Novel Foods in Canada William Yan, Ph.D. Office of Food Biotechnology Health Canada.
1 Promoting Safe Medicine With Track and Trace Systems SRC Technologies, Inc.
© 2012 Her Majesty the Queen in Right of Canada (Canadian Food Inspection Agency), all rights reserved. Use without permission is prohibited. Animal Feed.
Effectiveness Evaluation for Therapeutic Drugs for Non-Food Animals
1. RCC Industry Panel – Consumer Products Presentation to RCC Stakeholder Dialogue Session June 20, 2013 Darren Praznik President & CEO, Canadian Cosmetic,
Christian Asher.  there are more than 50,000 Dietary supplements available on the market today.  Dietary supplements are more popular than they’ve ever.
Dietary Supplements Bradford W. Williams Special Assistant Division of Dietary Supplement Programs ONPLDS, CFSAN, FDA.
The National Vaccine Plan Process - Update October 22, 2007 Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services.
EFSA MANAGEMENT PLAN 2008 The Management Plan
New Zealand Medicines and Medical Devices Safety Authority A business unit of the Ministry of Health.
© 2007 Her Majesty the Queen in Right of Canada (Canadian Food Inspection Agency), all rights reserved. Use without permission is prohibited. An Update.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
Implementing Shared Inspection Management Systems Insights from recent WBG research John R. Wille WBG Investment Climate Advisory Services Amman, Jordan.
Modernization of Health Canada Food Frameworks Foundations for Change Presentation to the Canadian Health Food Association June
 2011 Johns Hopkins Bloomberg School of Public Health Building Blocks for Effective Tobacco Product Regulation Section B.
Drug Submissions: Review Process Agnes V. Klein, MD Biologics and Genetic Therapies Directorate February, 2003 www/hc-sc.gc.ca/hpb-dgps/therapeut.
Best Practices: Where Industry Should Lead on Ensuring Proper Testing & Auditing Stephen F. Sundlof, DVM, PhD Senior Advisor for Animal and Food Safety.
Cavendish Scott, Inc. 1 Regulatory and Statutory Compliance: It’s Everybody’s Business! Diana Lough Cavendish Scott, Inc.
The Canadian Regulatory View of Insect Resistance Management Entomological Society of America Meeting, Indianapolis, Indiana December 2009 Heather McBrien.
Research Governance Dr. Sheila Francis
Council for Responsible Nutrition FDA Public Meeting on New Dietary Ingredients Annette Dickinson, Ph.D. November 15, 2004.
DIETARY SUPPLEMENTS Dietary supplements are products that can be added to people’s diets. They include vitamins, minerals, herbs, and amino acids.
Review of veterinary medicines legislation in 2010 Mario Nagtzaam Unit F2 „Pharmaceuticals“ Directorate-General Enterprise and Industry European Commission.
FEDERAL “RELATED SCIENCE ACTIVITIES” (RSA) AND MULTI-LEVEL REGULATION  INTRODUCTION AND CENTRAL PURPOSES  RSA AND LEVELS OF SCIENCE-BASED REGULATION.
Produce Industry Perspectives on Cross-Border Issues Canada-United States Transportation Border Working Group Fall Plenary Bev Appleby, CPMA October 28,2010.
Dispensary and Administration Site Information Presentation.
FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology July 22-23, 2008 Introduction and Update Helen N. Winkle Director, Office of.
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
1 Outcome of the 4 th Global Animal Health Conference (GAHC) June 2015 Bettye K. Walters, DVM US Food and Drug Administration
VICH General Principles and current update of VICH Outreach Forum activity 1.
VICH Training Strategy Steven D. Vaughn, DVM Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine U.S. Food and Drug Administration.
Regulatory Overview of Complementary Medicines in South Africa Dr A T Sigobodhla Session : VICH Outreach Forum Tokyo, Japan: 26 – 27 October 2015.
Medical Device Regulations in Canada; Key Challenges and International Initiatives.
Regulating Winemaking Practice Additions in a Rapidly Evolving, Global Market Greg Hodson 7 th May, 2015.
Industry: trends, concerns hopes and ideas VICH5 Conference Carel du Marchie Sarvaas, Executive Director October 2015.
-What is VICH, History and Objectives Hervé MARION, DVM VICH Secretariat.
1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.
1 CHALLENGES IN REGULATION OF TRADITIONAL AND ALTERNATIVE MEDICINES 24 th March, 2010 MOHSW Conference Room Registration of Herbal Drugs.
An agency of the European Union Principles for the assessment and authorisation of antimicrobials in the EU VICH Outreach Forum, October 2015 Presented.
The Benefits of VICH to VICH Member Countries and Regions DONALD A. PRATER, DVM Director, U.S. FDA Europe Office Office of International Programs Office.
Regulation of Generic Animal Drugs in the United States
1 Introduction. What are functional foods? Pangan yang dirancang tidak hanya untuk memenuhi kebutuhan dasar dalam energi, makronutrien (protein, KH dan.
The Adverse Experience Reporting Program (AERP). Industrial and domestic chemicals – NICNAS (National Industrial Chemicals Notification and Assessment.
1 THE OIE REPORT 32 nd VICH SC Meeting / 6 th VICH Outreach Forum Meeting Jean-Pierre Orand, Anses, France, OIE Collaborating Centre.
Introduction to the Canadian Food Safety System Roles and Responsibilities in Food Surveillance December 9, 2013 Samuel Godefroy, Ph.D. Director General,
1 PHARMACOVIGILANCE & THE NATIONAL ADVERSE DRUG REACTION (ADR) REPORTING SYSTEM Sarah Spiteri Post-Licensing Directorate Medicines Authority.
1 1 Topics “out of the scope of VICH” Brigitte Boenisch IFAH-Europe 2 nd VICH Outreach Forum Meeting Washington, 19 th /20 th February 2012 – how and by.
1 Improving the agenda for SWITCH for nonprescription Medicines Sheila Kelly WSMI September 2015.
Regulatory Updates Health Sciences Authority Singapore
Efficacy and Safety of Medicines
Karen Proud, President Consumer Health Products Canada
Dietary Supplements: What you should know
Helen Lee, European Commission
Chemical substances self – classification issues Lithuanian approach
Melanie Cummings Regulatory Specialist
AGRICULTURAL & VETERINARY CHEMICALS REGULATION IN AUSTRALIA
Beyond Academia.
Safety Guidelines Illness and Injury Prevention
How Can I Get More Information on VICH?
Canada’s Strategy for a Safe and Nutritious Food Supply
Safety Guidelines Illness and Injury Prevention
Safety Guidelines Illness and Injury Prevention
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA
Presentation transcript:

Health Canada’s Approach to Low Risk Veterinary Health Products: Interim Notification Pilot Program Veterinary Drugs Directorate-Health Canada Presented to the VICH Outreach Forum October, 2015

Health Canada/Veterinary Drugs Directorate Mandate Health Canada is responsible for protecting human and animal health and the safety of Canada's food supply. Through the Veterinary Drugs Directorate, Health Canada evaluates and monitors the safety, quality and effectiveness, sets standards and promotes the prudent use of veterinary drugs administered to food-producing and companion animals. 2

Health Canada/Veterinary Drugs Directorate Act, Regulations & Guidelines Food and Drug Regulations Food and Drugs Act The Veterinary Drugs Directorate (VDD) applies the Food and Drug Regulations under the authority of the Food and Drugs Act international guidelines Data requirements according to international guidelines for veterinary drugs VICH VICH 3

Health Canada/Veterinary Drugs Directorate HC-VDD website: mps/vet/index-eng.phphttp:// mps/vet/index-eng.php Note: Health Canada does not have authority over the practice of veterinary medicine (Provincial jurisdiction) 4

Veterinary Drug Regulation/Approval Current process Pre-market approval requirements: Manufacturing and quality controls Animal safety data Efficacy data Human safety data (Food producing animals) mps/vet/legislation/guide-ld/vdd-guide-ands-padn- eng.phphttp:// mps/vet/legislation/guide-ld/vdd-guide-ands-padn- eng.php 5

Low-risk Veterinary Health Products Issues (1) Increased demand Increased demand for low-risk veterinary health products such as vitamins, minerals, homeopathics, probiotics and botanical products among others challenges Members of the industry faced challenges in meeting current regulatory requirements (not adapted to these products) Drug regulatory framework – one size fits all, regardless of risk 6

Low-risk Veterinary Health Products Issues (2) without regulatory scrutiny A number of these products marketed or imported for sale in Canada without regulatory scrutiny or appropriate market authorization unknown to Health CanadaQuality, safety and efficacy unknown to Health Canada compliance actionRegulatory compliance action in Canada / at the border 7

Interim Notification Pilot Program: New Option simplified registration2012: A voluntary option of simplified registration for Low- Risk Veterinary Health Products for companion animals low risk products only Health Canada sets standards - low risk products only Notification Number Notified products have a Notification Number on label (ex. NN.1A2B) not prioritize the enforcement Health Canada would not prioritize the enforcement of the regulatory requirements for such products 8 4

Interim Notification Pilot Program: Development (1) industry and science experts Standards developed in consultation with industry and science experts Recommendation of the Expert Advisory Committee (2010) INPP consultation - strong stakeholder support (2011) Flexible approach to product regulation Reduction of administrative burden for Industry 9

Interim Notification Pilot Program: Development (2) Administrative process Administrative process in collaboration with third party administrator Customized Database, e-forms List of Admissible Substances List of Admissible Substances Researched over 5500 ingredients (vitamins, minerals, homeopathic, herbal, excipients etc) Harmonization Harmonization Information from other directorates, agencies (eg NHPD, CFIA, Food) and international resources (eg US GRAS, EU directives) 10

Interim Notification Pilot Program Design (1) cats, dogs and horses Only for products intended for use in cats, dogs and horses Great interest from stakeholders on an approach for food producing animals pre-cleared ingredients Only pre-cleared ingredients oral /topical/otic Only oral /topical/otic (ear) route of administration general health claims Only general health claims 11

Interim Notification Pilot Program Permitted claims General Health Claims maintenance Refer to the maintenance of normal physiology, not to its modification “Helps maintain”, “supports”, “enhances”, “has a role in”, “contributes to” disease, condition or injury Not associated with a specific disease, condition or injury Structure or physiological function “Maintains joint and bone health” vs “Treats osteoarthritis” 12

Interim Notification Pilot Program Design (2) Health Canada Health Canada sets eligibility standards (Safety, Efficacy, Quality) Sponsor Sponsor attests to compliance (evidence on hand) Third Party Program administered by Third Party verifies eligibility issues NNs on fee-for-service basis 13

Interim Notification Pilot Program: Outcomes(1) Notified Products since March 2012 (642 active) ingredients permitted with qualifications ~3800 Homeopathic ~750 Non-Medicinal ~135 TCM ~640 Active (plant, animal, chemical) 14

15

Interim Notification Pilot Program: Outcomes(2) custom madeUse of custom made software Database and e-forms- Product Notification, New Substance Application and Adverse Event reporting (interconnected) TestedTested and fine-tuned registration model Potential to be expanded to food producing animal products in the new regulatory framework 16

Interim Notification Pilot Program: Benefits (1) safety 1. Increased general safety Low risk ingredients only Knowledge of manufacturing site (traceability/recalls) Proper labelling/manufacturing standards Adverse event reporting In/out system (Regulations still apply) 19

Interim Notification Pilot Program Benefits (2) Increased access 2. Increased access to Low-risk products for animals Easier/faster process - reduced requirements/less costly Low priority for regulatory compliance enforcement by Health Canada 20

Interim Notification Pilot Program: Benefits (3) burden 3. Reduced burden and cost for client Simple registration process Reduced requirement for evidence data time to market 4. Reduced time to market for new products 1-4 weeks vs 300 days for conventional products resources 5. No increase in government resources Administration by third party 21

Interim Notification Pilot Program: Summary Reduced administrative and financial burden on Industry without compromising health and safety of Canadians and animals 22 15

Interim Notification Pilot Program: More info or enjeux/notification-declaration-eng.php 23